Form 4: Orthofix Officer Sells Shares to Cover Tax Obligations
SEC Form 4
Patrick Fisher, President of Global Orthopedics at Orthofix Medical Inc., sold 1,996 shares of common stock to cover tax obligations related to the settlement of restricted stock units.
Summary
- Patrick Fisher, President, Global Orthopedics at Orthofix Medical Inc., sold 1,996 shares of common stock on August 18, 2025.
- The sale was executed at a price of $14.21 per share.
- The transaction was to satisfy tax withholding obligations related to the settlement of restricted stock units.
- Following the transaction, Fisher directly owns 30,116 shares of Orthofix Medical Inc.
- This includes 24,936 restricted stock units and 2,070 shares acquired under Orthofix's Stock Purchase Plan on 4/30/2025.
Sentiment
Score: 5
Explanation: The filing represents a routine transaction related to tax obligations and does not indicate any significant positive or negative sentiment.
Positives
- The sale was part of a pre-existing sell-to-cover requirement approved by the Compensation and Talent Development Committee.
- The sale was mandated by the company, and the reporting person had no discretion over the sale.
Future Outlook
There are no explicit forward-looking statements in this filing.
Management Comments
- The sale was made without the exercise of any discretion by the reporting person.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It is common for executives to sell shares to cover taxes upon the vesting of restricted stock units.
Comparison to Industry Standards
- Sell-to-cover transactions are a standard practice in executive compensation across publicly traded companies.
- Many companies, such as Medtronic, Stryker, and Johnson & Johnson, have similar programs in place for their executives.
- The amount of shares sold is relatively small compared to the executive's total holdings, which is typical for these types of transactions.
Stakeholder Impact
- Minimal impact on shareholders as the transaction is related to tax obligations and does not reflect a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 2025-04-30 | Date shares were acquired under Orthofix's Stock Purchase Plan |
| 2025-08-18 | Date of the transaction (stock sale) |
| 2025-08-20 | Date of signature on the Form 4 filing |
Keywords
Orthofix Medical Inc., Patrick Fisher, stock sale, Form 4, restricted stock units, tax obligations, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.